# Lonza Houston, Inc, Houston, TX – FDA Inspections

Source: https://www.keypedia.com/companies/lonza-houston-inc/c3ae4db9-9aba-4b65-9e2b-06e1632112a6

> Inspection records and compliance data for Lonza Houston, Inc in Houston, Texas. 3 FDA inspections on record, 1 Form 483, last inspected November 26, 2025.

---

## Details

- Name: Lonza Houston, Inc
- FEI Number: 3013629214
- Facility Type: Manufacturer - Viral Vector
- Address Line 1: 14905 Kirby Dr
- City: Houston
- State: Texas
- Zip Code: 77047
- Country Name: United States
- Address: 14905 Kirby Dr, Houston, Texas 77047, United States
- Country: United States

## Related Documents

- [FDA Inspection 1302682 - Lonza Houston, Inc - 2025-11-26](https://www.keypedia.com/records/fda_inspections/lonza-houston-inc/dad36cf8-018a-42e8-9835-d91ec9c9e3c7) — source: FDA, date: November 26, 2025
- [483 - Lonza Houston, Inc - 2025-11-18](https://www.keypedia.com/records/483/lonza-houston-inc/e418f58e-2cfe-4e4a-b05c-26a75097a51a) — source: FDA, date: November 18, 2025
- FDA Inspection 1239768 - Lonza Houston, Inc - 2024-02-02 — source: FDA, date: February 2, 2024
- [EIR - Lonza Houston, Inc - 2022-02-18](https://www.keypedia.com/records/eir/lonza-houston-inc/9dbe5d45-4d0c-49af-997c-4fea18914efa) — source: FDA, date: February 18, 2022
- [EIR - Lonza Houston, Inc - 2020-12-10](https://www.keypedia.com/records/eir/lonza-houston-inc/69db7a95-168c-4a69-b1bd-bb1554c5ff03) — source: FDA, date: December 10, 2020
- [483 - Lonza Houston, Inc - 2020-12-10](https://www.keypedia.com/records/483/lonza-houston-inc/f76f8011-47f3-43b0-b2ad-55b6f6aa2545) — source: FDA, date: December 10, 2020
- [FDA Inspection 1133868 - Lonza Houston, Inc - 2020-12-10](https://www.keypedia.com/records/fda_inspections/lonza-houston-inc/579c26d0-be06-4fcc-9ffe-dc6c9b208e4f) — classification: No Action Indicated (NAI), source: FDA, date: December 10, 2020

## Related Companies

- [Adaptimmune LLC](https://www.keypedia.com/companies/adaptimmune-llc/6394510c-b8e5-4662-a4f9-e3f788e5adcb)
- [SciVac Ltd](https://www.keypedia.com/companies/scivac-ltd/8c2211b8-69bf-4d8f-be85-9429be552876)
- [Juno Therapeutics, Inc.](https://www.keypedia.com/companies/juno-therapeutics-inc/d564709e-29d0-4aaf-9d68-efbf3cd67a35)
- [Replimune, Inc.](https://www.keypedia.com/companies/replimune-inc/aed2f3d2-d153-4e38-af9b-19febd6fd927)
- [Bavarian Nordic Berna GmbH](https://www.keypedia.com/companies/bavarian-nordic-berna-gmbh/c041bdf1-c3d5-46c3-a216-02ad314f45e0)
- [Novartis Pharmaceuticals Corporation](https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47)
- [Serum Institute of India Pvt. Ltd.](https://www.keypedia.com/companies/serum-institute-of-india-pvt-ltd/a1288932-02ec-49e6-942a-e8d90c93b890)
- [SAFC Carlsbad Inc.](https://www.keypedia.com/companies/safc-carlsbad-inc/764cba2a-82e8-41a9-b19f-145bdafcd432)
- [Kite Pharma, Inc.](https://www.keypedia.com/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f)
- [Emergent Biodefense Operations Lansing LLC](https://www.keypedia.com/companies/emergent-biodefense-operations-lansing-llc/7a502584-4071-4f7a-bb11-7272db98f478)

## Related Officers

- [Compliance Officer at FDA](https://www.keypedia.com/people/lauren-m-lilly/41582ad0-67b1-4c60-99e2-c1e3c63811c2)
- [Scott T. Ballard](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [Principal Consultant- CMC Biologics, Former FDA regulator with expertise in CMC and GMP for Biologics](https://www.keypedia.com/people/steven-e-bowen/0e32c7e6-285b-4cf1-90e1-8a7a12a38b0c)
- [investigator](https://www.keypedia.com/people/christian-d-lynch/3b2748d3-3800-4538-939d-71a33dca0b2d)
- [investigator](https://www.keypedia.com/people/wei-wang/943039ac-3917-4d32-9f58-1886c56aecdd)